Cronos Group (TSX:CRON) is back in focus after a proposed US$10,000,000 settlement aimed at resolving U.S. and Ontario securities class actions tied to trades between May 2019 and March 2020.
The proposed settlement lands at a time when Cronos Group’s share price has been rebuilding momentum. The latest close was CA$4.61, with a 90 day share price return of 15.54% and a 1 year total shareholder return of 27.35%, even though the 5 year total shareholder return is down 32.31%.
Scan how Cronos Group compares with other cannabis and healthcare names showing momentum and cleaner balance sheets using our curated list of solid balance sheet and fundamentals (7 results)
That rebound in Cronos Group raises a simple tension. Is the recent climb pointing to progress in the underlying cannabis business, or is it mostly a reset in sentiment after the proposed settlement headlines?
Most Popular Narrative: 12% Undervalued
Cronos Group’s most followed narrative pegs fair value at CA$5.24, which sits above the latest CA$4.61 close and presents the stock as modestly discounted based on updated growth and risk assumptions filtered through a 6.44% discount rate.
Strategic investment capacity, supported by a strong balance sheet with $834 million in cash and zero debt, enables Cronos to pursue further product innovation, international expansion, and value-accretive partnerships, which may positively influence net margins and future earnings growth.
See why 10 investors see Cronos Group as 12% undervalued.
Result: Fair Value of CA$5.24 (UNDERVALUED)
Still, Cronos Group’s dependence on GrowCo expansion and its heavy exposure to Canada and Israel could quickly challenge this undervalued narrative if operations or regulations disappoint.
Find out about the key risks to this Cronos Group narrative.
Next Steps
Mixed signals on Cronos Group so far. If you want to move quickly and build your own view off the data, start by weighing the 3 key rewards and 1 important warning sign
Looking for more investment ideas beyond Cronos Group?
If Cronos Group has your attention, broaden your watchlist now and give yourself more options before the next round of market-moving headlines arrives.
- Hunt for potential value opportunities that pair solid fundamentals with room for re-rating through our focused 6 high quality undervalued stocks.
- Build a steadier income stream by scanning companies that target higher yields and resilience using the income focused 1 dividend fortresses.
- Sleep easier at night by filtering for companies that score well on resilience metrics through our 8 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com